Exploring the manifestations of anxiety in children with autism spectrum disorders

Journal of Autism and Developmental Disorders

Volumn 43, Issue 10, 2013, Pages 2341-2352

  Hallett, Victoria ^a,p   Lecavalier, Luc ^b   Sukhodolsky, Denis G ^a   Cipriano, Noreen ^a   Aman, Michael G ^b   McCracken, James T ^c   McDougle, Christopher J ^d   Tierney, Elaine ^e   King, Bryan H ^f   Hollander, Eric ^g   Sikich, Linmarie ⁱ   Bregman, Joel ^j   Anagnostou, Evdokia ^h   Donnelly, Craig ^k   Katsovich, Lily ^a   Dukes, Kimberly ^l,m   Vitiello, Benedetto ⁿ   Gadow, Kenneth ^o   Scahill, Lawrence ^a,q  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e KENNEDY KRIEGER INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h University of Toronto   (Canada)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j Center for Autism   (United States)

^k DARTMOUTH MEDICAL SCHOOL   (United States)

^l DM STAT Inc   (United States)

^m BOSTON UNIVERSITY   (United States)

ⁿ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^o STONY BROOK UNIVERSITY   (United States)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Anxiety; Autism spectrum disorders; Clinical Trials; Measurement

Indexed keywords

CITALOPRAM; PLACEBO; RISPERIDONE;

ABERRANT BEHAVIOR CHECKLIST; ADOLESCENT; ANXIETY DISORDER; ARTICLE; AUTISM; CASI SCALE; CHECKLIST; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DSM-IV; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESSNESS; RISK FACTOR; SCHOOL CHILD; SEPARATION ANXIETY; SLEEP AROUSAL DISORDER; SLEEP DISORDER; SOCIAL PHOBIA; SYMPTOM; TENSION;

ADOLESCENT; ANXIETY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; LANGUAGE DEVELOPMENT; MALE;

EID: 84884986781     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-013-1775-1     Document Type: Article

References (41)

1. Aman, M. G.; McDougle, C. J.; Scahill, L.; Handen, B.; Arnold, L. E.; Johnson, C.; et al. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(12),1143-1154.
2. Aman, M. G.; Singh, N. N.; Stewart, A. W.; & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American journal of mental deficiency, 89(5), 485-491.
3. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: American Psychiatric Association.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
5. Brown, E. C.; Aman, M. G.; & Havercamp, S. M. (2002). Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Research in Developmental Disabilities, 23(1), 45-60.
6. Browne, M. W.; Cudeck, R.; Tateneni, K.; & Mels, G. (2009). CEFA: Comprehensive exploratory factor analysis, version 3.04. [Computer Software and Manual].
7. Canitano, R. (2006). Self injurious behavior in autism: Clinical aspects and treatment with risperidone. Journal of neural transmission, 113(3), 425-431.
8. Costello, E. J.; Egger, H. L.; & Angold, A. (2005). The developmental epidemiology of anxiety disorders: Phenomenology, prevalence, and comorbidity. Child and adolescent psychiatric clinics of North America, 14(4), 631-648.
9. Gadow, K. D.; DeVincent, C. J.; Pomeroy, J.; & Azizian, A. (2004). Psychiatric symptoms in preschool children with PDD and clinic and comparison samples. Journal of Autism and Developmental Disorders, 34(4), 379-393.
10. Gadow, K. D.; Devincent, C. J.; Pomeroy, J.; & Azizian, A. (2005). Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism: The International Journal of Research and Practice, 9(4), 392-415.
11. Gadow, K. D.; & Sprafkin, J. (1998). Adolescent symptom inventory-4 norms manual (Vol. Stony Brook, NY: Checkmate Plus). Stony Brook, NY: Checkmate Plus.
12. Gadow, K. D.; & Sprafkin, J. (2002). Child symptom inventory-4 screening and norms manual. Stony Brook, NY: Checkmate Plus.
13. Goodman, W. K.; Price, L. H.; Rasmussen, S. A.; Mazure, C.; Fleischmann, R. L.; Hill, C. L.; et al. (1989). The yale-brown obsessive compulsive scale: 1. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006-1011.
14. Ivarsson, T.; & Melin, K. (2008). Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD). Journal of Anxiety Disorders, 22(6), 969-978.
15. Jensen, J. A.; & Armstrong, R. J. (1985). Slosson intelligence test for children and adults. East Aurora, NY: Slosson Educational Publications.
16. Jöreskog, K. G.; & Sörbom, D. (2004). LISREL 8.7 for Windows [Computer Software]. Lincolnwood, IL: Scientific Software International, Inc.
17. Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2(3), 217-250.
18. Kim, J. A.; Szatmari, P.; Bryson, S. E.; Streiner, D. L.; & Wilson, F. J. (2000). The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism: The International Journal of Research and Practice, 4(2), 117-132.
19. King, B. H.; Hollander, E.; Sikich, L.; McCracken, J. T.; Scahill, L.; Bregman, J. D.; et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583-590.
20. Le Couteur, A.; Lord, C.; & Rutter, M. (2003). Autism diagnostic interview-revised. Los Angeles: Western Psychological Services.
21. Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36(8), 1101-1114.
22. Marshburn, E. C.; & Aman, M. G. (1992). Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental-retardation. Journal of Autism and Developmental Disorders, 22(3), 357-373.
23. Mazurek, M. O.; & Kanne, S. M. (2010). Friendship and internalizing symptoms among children and adolescents with ASD. Journal of Autism and Developmental Disorders, 40(12), 1512-1520.
24. McDougle, C. J.; Scahill, L.; Aman, M. G.; McCracken, J. T.; Tierney, E.; Davies, M.; et al. (2005). Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. The American journal of psychiatry, 162(6), 1142-1148.
25. Mullen, E. (1995). Mullen scales of early learning. Circle Pines, MN: American Guidance Service.
26. Pine, D. S.; Guyer, A. E.; Goldwin, M.; Towbin, K. A.; & Leibenluft, E. (2008). Autism spectrum disorder scale scores in pediatric mood and anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 47(6), 652-661.
27. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347(5), 314-321.
28. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62(11), 1266-1274.
29. Roid, G. H.; & Miller, L. J. (1997). Leiter international performance scale-revised. Wood Dale, IL: Stoelting.
30. Scahill, L.; McCracken, J. T.; Bearss, K.; Robinson, F.; Hollander, E.; King, B.; et al. (2012). Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 42(3), 432-440.
31. Scahill, L.; McDougle, C. J.; Williams, S. K.; Dimitropoulos, A.; Aman, M. G.; McCracken, J. T.; et al. (2006). Children's yale-brown obsessive compulsive scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45(9), 1114-1123.
32. Scahill, L.; Riddle, M. A.; McSwiggin-Hardin, M.; Ort, S. I.; King, R. A.; Goodman, W. K.; et al. (1997). Children's yale-brown obsessive compulsive scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844-852.
33. Sparrow, S. S.; Balla, D. A.; & Cicchetti, D. V. (1984). Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Service.
34. Sprafkin, J.; Gadow, K. D.; Salisbury, H.; Schneider, J.; & Loney, J. (2002). Further evidence of reliability and validity of the Child Symptom Inventory-4: Parent checklist in clinically referred boys. Journal of Clinical Child and Adolescent Psychology, 31(4), 513-524.
35. Sukhodolsky, D. G.; Scahill, L.; Gadow, K. D.; Arnold, L. E.; Aman, M. G.; McDougle, C. J.; et al. (2008). Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology, 36(1), 117-128.
36. van Steensel, F. J.; Bogels, S. M.; & Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical child and family psychology review. 14(3), 302-317.
37. Wechsler, D. (1989). Wechsler preschool and primary scale of intelligence-revised. San Antonio, TX: The Psychological Corporation.
38. Wechsler, D. (1991). Wechsler intelligence scale for children (3rd ed.). San Antonio, TX: The Psychological Corporation.
39. Weisbrot, D. M.; Gadow, K. D.; DeVincent, C. J.; & Pomeroy, J. (2005). The presentation of anxiety in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15(3), 477-496.
40. White, S. W.; Oswald, D.; Ollendick, T.; & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216-229.
41. Witwer, A. N.; & Lecavalier, L. (2010). Validity of comorbid psychiatric disorders in youngsters with autism spectrum disorders. Journal of Developmental and Physical Disabilities, 22(4), 367-380.